Penicillamine for Scleroderma

Abstract
Five patients with advanced systemic scleroderma were treated with high doses of D-penicillamine for periods up to 11 months. Careful measurement of mobility of involved joints before and after therapy revealed no improvement. Side effects occurred in all patients.

This publication has 0 references indexed in Scilit: